TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,467,760 | +12.6% | 203,632 | +100.0% | 0.01% | -33.3% |
| Q4 2021 | $4,857,000 | -27.3% | 101,815 | +1.2% | 0.01% | -36.8% |
| Q3 2021 | $6,683,000 | -55.8% | 100,598 | -48.1% | 0.02% | -13.6% |
| Q2 2021 | $15,120,000 | +96.1% | 193,792 | +137.8% | 0.02% | -4.3% |
| Q1 2021 | $7,710,000 | -20.9% | 81,506 | +1.9% | 0.02% | -25.8% |
| Q4 2020 | $9,748,000 | +22.0% | 79,996 | -12.5% | 0.03% | +6.9% |
| Q3 2020 | $7,990,000 | -53.0% | 91,466 | -65.3% | 0.03% | -14.7% |
| Q2 2020 | $17,002,000 | +31.8% | 263,234 | -8.9% | 0.03% | +6.2% |
| Q1 2020 | $12,900,000 | -32.1% | 288,852 | -5.3% | 0.03% | -17.9% |
| Q4 2019 | $19,008,000 | – | 305,138 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |